NeurologyLive® Friday 5 — February 20, 2026

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

Click the read more buttons for more details and information about each highlight.

1: Look Ahead in Neurology: What are Clinicians Excited About for 2026?

In this exclusive NeurologyLive video, Katrina Bawden, MSN, MSCN, FNP-C; Kathrin LaFaver, MD, FAAN, DipABLM; Brenda L. Wong, MD; Gerald Maguire, MD; and Mariana Hernandez Gonzalez-Monje, MD, PhD, discussed the emerging therapies and technologies they are most excited to see advance in neurology in 2026. [WATCH TIME: 9 minutes]

2: AI for Dementia Caregiver Training Could Reduce ER Visits and Transform Neurological Care at Home

In our latest guest feature, Neal K. Shah, CEO of CareYaya Health Technologies, discussed how AI-powered caregiver training platforms like YayaGuide can personalize dementia care education for family caregivers.

3: Analyzing the Differences Between Adolescent and Adult Multiple Sclerosis

In a recent interview at ACTRIMS Forum 2026, Yael Hacohen, MD, PhD, a pediatric neurologist at the UCL Institute of Neurology in London, England discussed how pediatric-onset MS is marked by intense inflammation, unique neurodevelopmental considerations, and evolving treatment paradigms. [WATCH TIME: 5 minutes]

4: NeuroVoices: Jeffrey Cohen, MD, on Stem Cell Strategies and the Future of Multiple Sclerosis Therapeutics

In our latest NeuroVoices Q&A, Jeffrey Cohen, MD, director of the Clinical Neuroimmunology Fellowship and professor of neurology at Cleveland Clinic, gave insights on hematopoietic stem cell transplantation, CAR T-cell strategies, and the ongoing challenges of developing immune reconstitution and repair therapies in multiple sclerosis.

5: Understanding Adjunct Thrombolysis After Thrombectomy in Large Vessel Occlusion Stroke

In a recent interview at ISC 2026, Angel Chamorro, MD, PhD, professor of neurology from the University of Barcelona, discussed the clinical implications of adding intra-arterial alteplase after thrombectomy in patients with large-vessel occlusion acute ischemic stroke. [WATCH TIME: 2 minutes]

Click here to view our latest video interview shorts with neurology experts.